• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Syra Health Wins New Workforce Contract, Announces Existing Contract Extension

    1/7/25 7:55:00 AM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary
    Get the next $SYRA alert in real time by email

    CARMEL, Ind., Jan. 7, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA) ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, announced today that the Washington D.C. government has awarded it a healthcare workforce contract, valued at up to $1 million, on behalf of the Office of the State Superintendent of Education. The Company also announced that the Indiana Family and Social Services Administration's NeuroDiagnostic Institute has increased its existing contract by $1.2 million, bringing the total value to $18.7 million.

    Syra Health - A catalyst for improving health outcomes. (PRNewsfoto/Syra Health)

    Syra Health will deploy registered nurses, licensed practical nurses, and certified nursing assistants to deliver healthcare services to students as part of Washington D.C.'s ongoing commitment to ensuring the safety and well-being of students. Under the agreement, Syra Health will supply services in compliance with D.C. regulations and adhere to strict guidelines to affirm timely and efficient care delivery. This includes developing individualized service plans for students. The one-year agreement includes multiple options for extensions.

    In addition to this new contract, Syra Health continues to expand its support for the Indiana Family and Social Services Administration's NeuroDiagnostic Institute. Syra Health provides healthcare professionals to the Institute to evaluate and treat patients with complex neuropsychiatric illnesses.

    "These contracts highlight our deep commitment to driving better health outcomes," said Dr. Deepika Vuppalanchi, CEO of Syra Health. "By providing tailored services that alleviate staffing shortages and ensure continuity of care, we are not only addressing immediate healthcare needs but also supporting long-term solutions. This marks our fourth contract with the Washington, D.C. government, and we are excited to continue our partnership with them. At the same time, we are eager to further strengthen our collaboration with the NeuroDiagnostic Institute, a valued partner since 2021."

    About Syra Health

    Syra Health is a healthcare technology company powering better health in critical areas such as behavioral and mental health, population health, and the healthcare workforce. The company's leading-edge technology and innovative services focus on prevention, access, and affordability. With a commitment to improving health, Syra Health is advancing healthcare solutions nationwide and around the world.

    Forward-Looking Statements 

    Statements in this press release about future expectations, plans, and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements." These statements include but are not limited to, statements relating to the expected use of proceeds, the Company's operations and business strategy, and the Company's expected financial results. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The forward-looking statements contained in this press release are based on management's current expectations and are subject to substantial risks, uncertainty, and changes in circumstances. Investors should read the risk factors set forth in our Form 10-K for the year ended December 31, 2023, and other periodic reports filed with the Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof, and, except as required by federal securities laws, the Company specifically disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise.

    For Investor or Media Inquiries:

    Christine Drury

    IR/PR

    Syra Health

    463-345-5180

    [email protected]

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/syra-health-wins-new-workforce-contract-announces-existing-contract-extension-302343703.html

    SOURCE Syra Health

    Get the next $SYRA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SYRA

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $SYRA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Syra Health Appoints Healthcare Executive and Former U.S. Marine Gregory R. Alexander as Chief Executive Officer to Drive Growth

    Proven C-Suite Leader with Track Record of Scaling Healthcare Organizations Joins Syra Health to Accelerate Market Expansion and Industry Impact CARMEL, Ind., Dec. 18, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB:SYRA) ("Syra Health" or the "Company"), a healthcare solutions company dedicated to powering better health outcomes through prevention-focused, accessible, and affordable solutions, announced today the appointment of Gregory R. Alexander as Chief Executive Officer, effective January 5, 2026. Alexander's career has been defined by consistently driving growth and excee

    12/18/25 8:55:00 AM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    Syra Health Announces Third Quarter Financial Results: Margins, Profitability Metrics Improve

    Q3 2025 Revenue of $1.7 MillionRevenue driven by 96% year-over-year growth in the Population Health segmentGross margin improved 300 basis points to 33% in Q3 2025 from 30% in Q3 2024Net loss decreased 46% year-over-yearEarnings per share improved to ($0.02) for Q3 2025 compared to ($0.6) for Q3 2024CARMEL, Ind., Nov. 12, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB:SYRA) ("Syra Health" or the "Company"), a healthcare solutions company dedicated to powering better health outcomes through prevention-focused, accessible, and affordable solutions, announced today its financial results for the third quarter ended September 30, 2025.

    11/12/25 7:55:00 AM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    Syra Health To Announce Third Quarter 2025 Financial Results

    CARMEL, Ind., Nov. 5, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB:SYRA), ("Syra Health" or the "Company"), a healthcare solutions company powering better health outcomes through innovative services and technology, announced today that it will report financial results for the three months ended September 30, 2025, on Wednesday, November 12, 2025. The results will be shared via press release before the market opens. About Syra Health Syra Health is a healthcare solutions company serving public and private healthcare organizations with innovative solutions that positively impac

    11/5/25 8:55:00 AM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    $SYRA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CFO and COO Prasad Priya bought $13,257 worth of shares (14,448 units at $0.92) and sold $10,144 worth of shares (4,153 units at $2.44) (SEC Form 4)

    4 - Syra Health Corp (0001922335) (Issuer)

    9/13/24 9:10:53 AM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    $SYRA
    SEC Filings

    View All

    Syra Health Corp. filed SEC Form 8-K: Leadership Update, Other Events, Financial Statements and Exhibits

    8-K - Syra Health Corp (0001922335) (Filer)

    12/18/25 9:48:37 AM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    Syra Health Corp. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

    8-K - Syra Health Corp (0001922335) (Filer)

    11/18/25 4:05:51 PM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    Syra Health Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Syra Health Corp (0001922335) (Filer)

    11/14/25 4:15:30 PM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    $SYRA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO Alexander Gregory R. was granted 110,537 units of Restricted Stock Units (SEC Form 4)

    4 - Syra Health Corp (0001922335) (Issuer)

    2/3/26 4:30:22 PM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    SEC Form 3 filed by new insider Alexander Gregory R.

    3 - Syra Health Corp (0001922335) (Issuer)

    1/14/26 5:05:31 PM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    SEC Form 3 filed by new insider Mereddy Radhika

    3 - Syra Health Corp (0001922335) (Issuer)

    1/13/26 4:54:25 PM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    $SYRA
    Leadership Updates

    Live Leadership Updates

    View All

    Syra Health Appoints Healthcare Executive and Former U.S. Marine Gregory R. Alexander as Chief Executive Officer to Drive Growth

    Proven C-Suite Leader with Track Record of Scaling Healthcare Organizations Joins Syra Health to Accelerate Market Expansion and Industry Impact CARMEL, Ind., Dec. 18, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB:SYRA) ("Syra Health" or the "Company"), a healthcare solutions company dedicated to powering better health outcomes through prevention-focused, accessible, and affordable solutions, announced today the appointment of Gregory R. Alexander as Chief Executive Officer, effective January 5, 2026. Alexander's career has been defined by consistently driving growth and excee

    12/18/25 8:55:00 AM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    Syra Health Board Begins CEO Search to Drive Growth

    CARMEL, Ind., May 20, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB:SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today that its Board of Directors will begin a national search for a new Chief Executive Officer to succeed current CEO Dr. Deepika Vuppalanchi. Dr. Vuppalanchi will serve as interim CEO until a successor is appointed. This leadership transition is part of a strategic succession plan designed to position Syra Health for its next phase of grow

    5/20/25 9:00:00 AM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    $SYRA
    Financials

    Live finance-specific insights

    View All

    Syra Health Announces First Quarter Revenue of $1.9 Million, Up 6% YoY

    Revenue increase led by Population Health's 261% YoY Expansion Gross Margin Improves Substantially to 31.7%, up 14.6 Percentage Points YoY Continued Efficiency Gains Cut Q1 2025 Net Losses by Over Two Thirds Compared to Q1 2024 A conference call will be held today, Thursday, May 8, at 9:00 am ET CARMEL, Ind., May 8, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB:SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today its financial results for the first quarter ended March 31, 2025.

    5/8/25 7:55:00 AM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    Syra Health To Discuss First Quarter 2025 Financial Results

    Conference call will be held on Thursday, May 8, at 9:00 a.m. ET CARMEL, Ind., May 1, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB:SYRA), ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today that it will report financial results for the three months ended March 31, 2025, on Thursday, May 8, 2025, before market open. The Company will host a conference call that same day, May 8, 2025, at 9:00 a.m. ET, to discuss the results. Interested parties can access the con

    5/1/25 8:55:00 AM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    Syra Health Announces Full-Year Revenue of $8.0 Million, Up 45% YoY

    2024 Population Health Revenue Acceleration to 132% YoY Q4 2024 Net Losses Cut Nearly in Half Compared to Q4 2023, Highlighting Major Efficiency Gains Continued Momentum with New Customer Wins and Contract Extensions Driving Sustainable Growth A conference call will be held today, Tuesday, March 11 at 9:00 am ET CARMEL, Ind., March 11, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today its financial results for fourth quarter and full year ended December 31, 2024.

    3/11/25 7:43:00 AM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    $SYRA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Syra Health Corp.

    SC 13G - Syra Health Corp (0001922335) (Subject)

    2/20/24 3:01:17 PM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary